Modulation of the immunological and neuroinflammatory microenvironment in older people with multiple sclerosis - Top-Institutions - MDSpire

Modulation of the immunological and neuroinflammatory microenvironment in older people with multiple sclerosis

  • By

  • Oreja-Guevara, Celia

  • Meuth, Sven G

  • Grigoriadis, Nikolaos

  • Vermersch, Patrick

  • Hartung, Hans-Peter

  • Sorensen, Per Soelberg

  • Leocani, Letizia

  • Schmierer, Klaus

  • Gold, Ralf

  • Fernández, Óscar Fernández

  • May 19, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    University of California, San Francisco
    University of California, San Francisco

    San Francisco, California

    Key Differentiators

    • Multiple Sclerosis
    • Neuroimmunology

  • #2

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, Maryland

    Key Differentiators

    • Neuroimmunology
    • Multiple Sclerosis

  • #3

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Multiple Sclerosis
    • Neuroimmunology

  • #4

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Multiple Sclerosis
    • Neuroimmunology

  • #5

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, Pennsylvania

    Key Differentiators

    • Multiple Sclerosis
    • Neuroimmunology

Original Source(s)

Modulation of the immunological and neuroinflammatory microenvironment in older people with multiple sclerosis

  • by Oreja-Guevara, Celia , Meuth, Sven G, Grigoriadis, Nikolaos , Vermersch, Patrick , Hartung, Hans-Peter , Sorensen, Per Soelberg , Leocani, Letizia , Schmierer, Klaus , Gold, Ralf , Fernández, Óscar Fernández

  • May 19, 2026

Related Content

Menopause and ageing in women with multiple sclerosis

Case Study: Ofatumumab-Induced Remission in Refractory Panuveitis Accompanied by Multiple Sclerosis

Epstein-Barr Virus-Associated Multiple Sclerosis: Recent Mechanistic Advances and Clinical Therapeutic Perspectives